Stockscreener 앱 받기
10.01
1.77%
-0.18
시간 외 거래:
9.95
-0.06
-0.60%
전일 마감가:
$10.19
열려 있는:
$10.19
하루 거래량:
1.13M
Relative Volume:
1.50
시가총액:
$348.61M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.5496
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
-5.48%
1개월 성능:
-18.88%
6개월 성능:
-38.40%
1년 성능:
+24.35%
1일 변동 폭
$9.87
$10.29
1주일 범위
$9.87
$13.44
52주 변동 폭
$7.1701
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.01 | 370.55M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Is Delcath Systems Inc. a turnaround storyBlue Chip Bargain Alerts - thegnnews.com
Delcath outlines 175% projected HEPZATO volume growth and targets up to 28 operational centers by year-end 2025 amid expanding clinical pipeline - MSN
Delcath Systems, Inc. Just Recorded A 200% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Delcath Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - uk.finance.yahoo.com
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates - MSN
Delcath Systems Reports Strong Q2 Growth Amid Challenges - The Globe and Mail
Delcath Systems 2025 Q2 Earnings Strong Performance as Net Income Surges 119.6% - AInvest
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $31 - 富途牛牛
Delcath Systems’ HEPZATO Drives Strong Growth and Expansion, Justifying Buy Rating - TipRanks
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - Insider Monkey
Delcath Systems (DCTH) Sees Analyst Target Price Raised by HC Wa - GuruFocus
We Like These Underlying Return On Capital Trends At Delcath Systems (NASDAQ:DCTH) - uk.finance.yahoo.com
Delcath Systems Reports Second Quarter 2025 Results and Business Highlights - BioSpace
Delcath Systems Reports Strong Q2 2025 Results - TipRanks
Delcath (DCTH) Q2 Revenue Jumps 210% - AOL.com
Delcath Turns The Corner With Record Sales And Profit - Finimize
Delcath’s Revenue Jumps As Cancer Kit Sales Climb - Finimize
Versus Systems Inc. shares rise 2.18% intraday after Delcath Systems, Inc. reported a net income of USD 2.7 million for Q2 2025. - AInvest
Delcath Systems: Navigating the High-Stakes Gamble of HEPZATO's 200% Volume Growth and 28-Operational-Center Scalability in a Fractured Oncology Market - AInvest
Transcript : Delcath Systems, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Delcath Systems Q2 2025: Contradictions Unveiled on NDRA Impact, Activation Timelines, and European Growth - AInvest
Earnings call transcript: Delcath Systems Q2 2025 earnings beat expectations - Investing.com India
Delcath Systems earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Delcath Systems Inc (DCTH) Q2 2025 Earnings: EPS of $0.07 Beats - GuruFocus
Delcath Systems Reports Second Quarter 2025 Results and Business Highlights | DCTH Stock News - GuruFocus
Interventional oncology firm Delcath's Q2 revenue beats estimates - MarketScreener
Does Delcath Systems Inc. stock perform well during market downturnsCapitalize on market shifts before others do - Jammu Links News
How strong is Delcath Systems Inc. company’s balance sheetInvest confidently with real-time market updates - Jammu Links News
What is Delcath Systems Inc. company’s growth strategyBuild wealth with long-term growth strategies - Jammu Links News
Should I hold or sell Delcath Systems Inc. stock in 2025Unstoppable investment returns - Jammu Links News
What institutional investors are buying Delcath Systems Inc. stockOutstanding capital appreciation - Jammu Links News
What makes Delcath Systems Inc. stock price move sharplyCapitalize on market momentum for profits - Jammu Links News
Is Delcath Systems Inc. stock overvalued or undervaluedUnmatched market performance - Jammu Links News
Why is Delcath Systems Inc. stock attracting strong analyst attentionMarket-crushing stock picks - Jammu Links News
When is IDEXX Laboratories Inc. stock expected to show significant growthMarket-beating performance - Jammu Links News
How volatile is Delcath Systems Inc. stock compared to the marketAchieve rapid portfolio appreciation today - Jammu Links News
What is the risk reward ratio of investing in Delcath Systems Inc. stockDiscover high-impact investment opportunities - jammulinksnews.com
What are the latest earnings results for Delcath Systems Inc.Unlock steady growth with low-risk stocks - Jammu Links News
Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai - Barchart.com
What catalysts could drive Delcath Systems Inc. stock higher in 2025Smart Portfolio Watchlist To Watch Now - Jammu Links News
Delcath Systems (NASDAQ:DCTH) Is In A Strong Position To Grow Its Business - 富途牛牛
Visual analytics tools that track Delcath Systems Inc. performanceProfit Target Planning with Exit Confidence - Newser
Why Delcath Systems Inc. stock attracts strong analyst attentionReliable Alerts for Daily Stock Movers Released - metal.it
Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference - BioSpace
Statistical indicators supporting Delcath Systems Inc.’s strengthAlpha Stock Picks with Chart Confirmation - Newser
Delcath Systems to Participate at the Canaccord Genuity 45th Ann - GuruFocus
Delcath Systems: Pioneering Growth in Interventional Oncology Amid Strategic and Regulatory Momentum - AInvest
Intrahepatic Cholangiocarcinoma Market: Epidemiology, - openPR.com
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):